What happened to Bliss GVS Pharma?
BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2022 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2021.
Is Bliss GVS a good buy?
Is Bliss GVS Pharma Ltd a good quality company? Past 10 year’s financial track record analysis by Moneyworks4me indicates that Bliss GVS Pharma Ltd is a average quality company.
Who is the owner of Bliss GVS Pharma?
You can view name of Chairman, CEO, CFO, Management Team, Board of Directors and Key Executives of Bliss GVS Pharma Ltd….PREMARKET.
|Gagan Harsh Sharma||Managing Director|
|S R Vaidya||Chairman & Ind.Director|
|Santosh Parab||Independent Director|
|Shilpa Bhatia||Independent Director|
What is Bliss GVS?
Bliss GVS primarily develops, manufactures and markets products across various therapeutic categories including Anti-fungal, Contraceptive, Laxative, Anti-haemorrhoidal, Anti-spasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, Antipyretic, Analgesic and several others.
What are the products of Bliss GVS Pharma?
Anti-Malarial Products Manufacturer
|Brand / Product Name||Composition||Pack Size|
|ASUNATE 50 SP KIT||Artesunate Tablet and Sulfadoxine BP+Pyrimethamine BP Tablet||1 x (6+2) Tabs|
|AZITHROMYCIN||Azithromycin Dihydrate USP equivalent to Azithromycin Anhydrous||1 x 10 Tabs|
|BENORMIN||Glibenclamide BP Metformin hydrochloride BP||1 x 10 Tabs|
Why is GVS Bliss share falling?
Shares of state-owned refiners fell as the company failed to meet investors’ expectations from its second interim dividend. The stock fell over 5 per cent as the company’s Rs. 5 per share interim dividend was much lower than expectations of Rs.